Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06637423
Title A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) (TroFuse-027)
Acronym TroFuse-027
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Michael G Oefelein Clinical Trials ( Site 0053) RECRUITING Bakersfield California 93301 United States Details
Hospital Universitario Virgen de la Victoria ( Site 0043) RECRUITING Malaga Andalucia 29010 Spain Details
Hospital Universitario 12 de Octubre ( Site 0042) RECRUITING Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field